提高药品采购能力的创新决策支持服务

Phattharat Songthung, K. Sripanidkulchai, Paithip Luangruangrong, R. Sakulbumrungsil, S. Udomaksorn, N. Kessomboon, Inthira Kanchanaphibool
{"title":"提高药品采购能力的创新决策支持服务","authors":"Phattharat Songthung, K. Sripanidkulchai, Paithip Luangruangrong, R. Sakulbumrungsil, S. Udomaksorn, N. Kessomboon, Inthira Kanchanaphibool","doi":"10.1109/SRII.2012.76","DOIUrl":null,"url":null,"abstract":"The cost of pharmaceutical products is one of the largest contributors of operating costs in providing healthcare services in Thailand. As drug prices change according to shifting market forces, the distribution of purchase prices for each drug varies according to the type of medication and the purchasing power of the healthcare provider. These changes can have significant impact on how well healthcare providers can effectively provide services. PAC-DSS (Pharmaceutical Acquisition Capability Decision Support Service) is an innovative decision support service that enables hospitals to pool together and share information to better understand current market prices and run analytics on drug prices in order to improve their operating costs. Our service allows users to interact with real pricing data to dissect various factors that can contribute to acquisition capabilities of individual drugs such as specific brand names or groups of drugs such as all brands of a given generic drug, without sacrificing individual providers' privacy as we do not disclose individual purchase prices. In developing PAC-DSS, we have had to address a range of technical challenges such as data privacy and alignment of disparate drug ontologies. In this paper, we describe PAC-DSS's service architecture, analytic services, and the benefit of PAC-DSS on improving healthcare services by lowering operating cost without sacrificing service quality. We also discuss the initial benefits from deployment of the service currently hosted by the Ministry of Public Health.","PeriodicalId":110778,"journal":{"name":"2012 Annual SRII Global Conference","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"An Innovative Decision Support Service for Improving Pharmaceutical Acquisition Capabilities\",\"authors\":\"Phattharat Songthung, K. Sripanidkulchai, Paithip Luangruangrong, R. Sakulbumrungsil, S. Udomaksorn, N. Kessomboon, Inthira Kanchanaphibool\",\"doi\":\"10.1109/SRII.2012.76\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The cost of pharmaceutical products is one of the largest contributors of operating costs in providing healthcare services in Thailand. As drug prices change according to shifting market forces, the distribution of purchase prices for each drug varies according to the type of medication and the purchasing power of the healthcare provider. These changes can have significant impact on how well healthcare providers can effectively provide services. PAC-DSS (Pharmaceutical Acquisition Capability Decision Support Service) is an innovative decision support service that enables hospitals to pool together and share information to better understand current market prices and run analytics on drug prices in order to improve their operating costs. Our service allows users to interact with real pricing data to dissect various factors that can contribute to acquisition capabilities of individual drugs such as specific brand names or groups of drugs such as all brands of a given generic drug, without sacrificing individual providers' privacy as we do not disclose individual purchase prices. In developing PAC-DSS, we have had to address a range of technical challenges such as data privacy and alignment of disparate drug ontologies. In this paper, we describe PAC-DSS's service architecture, analytic services, and the benefit of PAC-DSS on improving healthcare services by lowering operating cost without sacrificing service quality. We also discuss the initial benefits from deployment of the service currently hosted by the Ministry of Public Health.\",\"PeriodicalId\":110778,\"journal\":{\"name\":\"2012 Annual SRII Global Conference\",\"volume\":\"44 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2012 Annual SRII Global Conference\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/SRII.2012.76\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2012 Annual SRII Global Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/SRII.2012.76","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

在泰国,医药产品的成本是提供保健服务的运营成本的最大来源之一。由于药品价格会随着市场力量的变化而变化,每种药品的购买价格分布也会根据药品的类型和医疗保健提供者的购买力而变化。这些变化会对医疗保健提供者有效提供服务的能力产生重大影响。PAC-DSS(药品采购能力决策支持服务)是一项创新的决策支持服务,使医院能够汇集和共享信息,以更好地了解当前的市场价格,并对药品价格进行分析,以提高其运营成本。我们的服务允许用户与真实的定价数据进行交互,以剖析可能影响单个药物获取能力的各种因素,如特定的品牌名称或药物组,如给定仿制药的所有品牌,而不会牺牲个人供应商的隐私,因为我们不披露个人购买价格。在开发PAC-DSS时,我们必须解决一系列技术挑战,例如数据隐私和不同药物本体的对齐。在本文中,我们描述了PAC-DSS的服务体系结构、分析服务,以及PAC-DSS在不牺牲服务质量的情况下通过降低运营成本来改善医疗保健服务的好处。我们还讨论了部署目前由公共卫生部主办的这项服务的初步好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Innovative Decision Support Service for Improving Pharmaceutical Acquisition Capabilities
The cost of pharmaceutical products is one of the largest contributors of operating costs in providing healthcare services in Thailand. As drug prices change according to shifting market forces, the distribution of purchase prices for each drug varies according to the type of medication and the purchasing power of the healthcare provider. These changes can have significant impact on how well healthcare providers can effectively provide services. PAC-DSS (Pharmaceutical Acquisition Capability Decision Support Service) is an innovative decision support service that enables hospitals to pool together and share information to better understand current market prices and run analytics on drug prices in order to improve their operating costs. Our service allows users to interact with real pricing data to dissect various factors that can contribute to acquisition capabilities of individual drugs such as specific brand names or groups of drugs such as all brands of a given generic drug, without sacrificing individual providers' privacy as we do not disclose individual purchase prices. In developing PAC-DSS, we have had to address a range of technical challenges such as data privacy and alignment of disparate drug ontologies. In this paper, we describe PAC-DSS's service architecture, analytic services, and the benefit of PAC-DSS on improving healthcare services by lowering operating cost without sacrificing service quality. We also discuss the initial benefits from deployment of the service currently hosted by the Ministry of Public Health.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信